Saturday, February 4, 2012

Concerning the Activities of AR-Pharma on Araxes

November 26

To: Colonel M__________, Special Projects
From: Major Pepper Siamendes, Special Investigations Unit

Concerning the Activities of AR-Pharma on Araxes following the Saf Virus Outbreak

I. Background:

The Saf Virus, commonly called the "Black Pox", was first identified on the planet Araxes by Dr. Eliza Demanjrick of Hoto Nagi. Symptoms include dark pustules and stains to the surrounding tissue. Transmission and fatality rates are high.

Al Raqis council chamber transcripts indicate preliminary research into a cure was seized by the local government at the October 18 session of the Laandsrat. Soon after, AR-Pharma established a production facility in the region.

According to public records, a key ingredient of this early version of the cure is derived from the blood of members of the native born population. This form of the cure, later known as the "Blood Cure", remains controversial in the medical community to this day.

However, with the only proven cure to that point under local government control, a rush began to provide alternatives. Subsequent versions began to appear from recognized pharmaceutical sources and unregulated markets.

Nevertheless, despite the marketing of 'blood-free' products from other sources and the attempt by a number of governments to subsidize the manufacturing and distribution of alternatives, AR-Pharma continued to post healthy profits from the sale of its medicine.

-----

II. The Facility:

The AR Pharma production facility was located at the edge of the desert to the East of the Al Raqis settlement.

The one large, main door to the structure opened to the only landing pad and was heavily reinforced. No other exits were apparent. An automated sentry gun, placed on standby, was clearly visible on the eastern side of the landing pad. Large vats were stored both inside and outside of the building, waiting for transportation off world.

Lower interior levels contained open warehouse space, enclosed control terminals and processing tanks.

The second floor contained an office or packaging area.

The third floor contained an array of blood draining equipment, similar in design to equipment we found on the derelict ship 'Persephone'.

A crematorium was located in a side chamber on the second floor for the disposal of human remains.

A later upgrade to the facility included advanced harvesting equipment.

-----

Sealed Appendix to Report Concerning the Activities of AR-Pharma on Araxes

A total of three assaults took place against the AR-Pharma facility during the week of November 12 to 19. Our operations in the region have allowed us to construct the following timeline:

On November 12, elements of the UNSC 405th arrived at the AR-Pharma facility.

Quasi-human in appearance, these marines were seen entering the building and destroying storage vats.

These troops were joined by a black assault craft bearing the Registration No. 20341 and the call sign “Intruder”.

Persons disembarking included a woman in a Hoto Nagi uniform who appeared to take command of the operation. The group was accompanied by one Myrmidon. It was unclear in what capacity the Myrmidon was present.

The principals were followed back to the Al Raqis Medical Centre. The large windows of the medical centre permitted easy viewing of the activity within.

The principals gathered on the second floor. The group sat at a conference table and reviewed footage take in the AR-Pharma facility.

It was after this event that AR-Pharma announced an increase in security. Information on the type of sentry gun was forwarded to [the United Systems Directorate] as per our information sharing arrangement.

-----

On November 14, our listening post intercepted this transmission:

"Sentry down at coordinates 168/201/63"

This was followed a short time later by:

"Sentry down at coordinates 167/210/73"

Analysis indicates that these coordinates fall within the AR Pharma facility.

We have concluded that this marks the continuation of the Hoto Nagi operation to shut down AR-Pharma activities. It was after this event that AR-Pharma announced its first interruption in production.

-----

On November 19, there were reports of a further explosion heard across the settlement.

This final attack reduced the facility to rubble. Acrid, black smoke drifted across the settlement. Residents complained of difficulty breathing and nausea. Our agents in the area observed that the fire burned for days.

Timing indicates that this attack followed AR-Pharma final attempts at repair and equipment upgrading. It is unknown who was responsible for this explosion.

Friday, February 3, 2012

The Aleph

**Begin Encrypted Transmission**

November 23

Medical Examination Report

To: Major Pepper Siamendes, UAP Special Investigations Unit (SIU)
From: Captain Manda Soldi Westminster, UAP Special Projects seconded to SIU

Reference: Audrey Aurotharius and Audrey Aurotharius
Subject: Nanoprobe Medical Examination

Traditional methods of medical examination detailed in previous reports were interesting but created more questions than answered. Magnetic Resonance Imaging of the showed signs of both microgravity and gravitic shearing stress with a differential gradient varying from 10Gs to 4Gs over a 2 meter length. I received the authorization to send the reports for a consult at the Polytechnique.

Doctor Moira Aristocrat, a doctor attached to the Zenobian Medical Center, proposed a virtual nanoprobe imaging procedure that might be more illuminating. After a tour of the facility and a thorough orientation was given to Ms. Zdychava, she gave the authorization for the procedure. Dr. A was very patient and also gave the full tour of the facility to the twins.

The procedure involved injecting self-propelled nanoprobes, about the size of a bacterium, that would transmit images to a virtual imaging suite. We also had control of the probes and were able to actually collect samples that we could later extract when we withdrew the probes from the bloodstream, assuming that the probes were not destroyed by the body’s internal defenses.

We managed to take samples of several bacteria and a couple of viruses for later analysis. Bacteria and white blood cells destroyed three of our probes while we attempted to collect cell samples of a bloodclot and an amyloid plaque tumor we located. We were finally successful on both counts.

Thru trial and error we managed to learn where the greater dangers were located and were able to adeptly collect pathogen and cell samples with minimal risk.

Finally, we located what we think might be the item of interest in one of the two girls. A very sophisticated self-replicating nanobot which is constructed in parts by the girl’s own cells. It is a sophisticated nanobot with robust defenses. After several attempts, we were finally able to obtain a usable sample. We suspect that this is the Aleph that the A.R.D.R.A. unit was looking for.

Preliminary analysis indicates that it is constructed in part with neural microtubules and appears to have some structures similar to the quantum circuits found in the Arudra unit that we captured with the assistance of Dr. Serendipity. We will do what non-destructive tests that we can and then call him in for a consult.

Reports to follow.

Captain Manda Soldi Westminster,
UAP Special Projects seconded to SIU


Cc: Colonel Aodhfionn MacMoragh

**End Encrypted Transmission**